Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
about
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.
P2860
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en-gb
type
label
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en-gb
prefLabel
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en-gb
P2093
P2860
P50
P1154
2-s2.0-85020703821
P1476
Treatment outcome in early dif ...... ma Observational Study (ESOS).
@en
P2093
Alexander J MacGregor
Alexandra Balbir-Gurman
Alison C Jordan
Anna Rudin
Anne Laure Fauchais
Ariane L Herrick
Brigitte Coppere
Christian Agard
Christine Serratrice
Christopher P Denton
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-210503
P407
P50
P5530
P577
2017-02-10T00:00:00Z
P6179
1083781875